rectal cancer
Conditions
Interventions
from POD 0 - POD 2 route of administration of morphine continuous epidural infusion (0.26 mg /day)
from POD 0 - POD 2 iv-PCA(continuous infusion: none, bolus: 1 mg, lockout time: 15 min)
Sponsors
Sapporo Medical University School of Medicine Clinical Department
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA-PS I-II
Exclusion criteria
Exclusion criteria: case of ASA-PS > III case of body weight < 40 kg case of BMI > 35 kg/m2 Bronchial asthma, emphysema complicated case Heart failure case Liver / kidney disfunction case ECG abnormal case (QT extension etc.) Patients with Parkinson's disease Alcohol and drug abuse history cases Cases with a history of allergy to morphine, local anesthetics and other analgesics Cases who consent can not be obtained
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| analgesia from postoperatve day(PID)0 to POD 2 pain score the consumption of morphine and additional analgesics recovery of bowel function from POD 0 to POD 2 | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse effects from POD 0 to POD 2 postoperative nausea and vomiting sedation respiratory defect patient's satisfaction at POD 1, 2 using QoR-40 sheets | — |
Countries
Japan
Contacts
Public ContactYukitoshi Niiyama
Sapporo Medical University, School of Medicine Department of Anesthesiology
Outcome results
None listed